A Comprehensive Tyrosine Phosphoproteomic Analysis Reveals Novel Components of the Platelet CLEC-2 Signaling Cascade

被引:22
|
作者
Izquierdo, Irene [1 ,2 ]
Barrachina, Maria N. [1 ,2 ]
Hermida-Nogueira, Lidia [1 ,2 ]
Casas, Vanessa [3 ]
Moran, Luis A. [1 ,2 ]
Lacerenza, Serena [4 ]
Pinto-Llorente, Roberto [3 ]
Eble, Johannes A. [5 ]
de los Rios, Vivian [6 ]
Dominguez, Eduardo [1 ,2 ]
Loza, Maria, I [1 ,2 ]
Ignacio Casal, Jose [6 ]
Carrascal, Montserrat [3 ]
Abian, Joaquin [3 ]
Garcia, Angel [1 ,2 ]
机构
[1] Univ Santiago de Compostela, Ctr Res Mol Med & Chron Dis CIMUS, Avda Barcelona S-N, Santiago De Compostela 15782, Spain
[2] IDIS, Santiago De Compostela, Spain
[3] Spanish Natl Res Council IIBB CSIC IDIBAPS, Inst Biomed Res Barcelona, CSIC UAB Prote Lab, Barcelona, Spain
[4] Univ Pisa, Dept Pharm, Pisa, Italy
[5] Univ Munster, Inst Physiol Chem & Pathobiochem, Munster, Germany
[6] CSIC, Prote Facil, CIB, Madrid, Spain
基金
欧盟地平线“2020”;
关键词
platelets; CLEC-2; signaling; tyrosine phosphoproteome; COLLAGEN RECEPTOR; INTEGRIN ALPHA(IIB)BETA(3); PHOSPHOLIPASE C-GAMMA-2; PROTEOMIC ANALYSIS; ACTIVATION MOTIF; GLYCOPROTEIN VI; ADAPTER PROTEIN; PHOSPHORYLATION; SYK; ROLES;
D O I
10.1055/s-0039-3400295
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
C-type lectin-like receptor 2 (CLEC-2) plays a crucial role in different platelet-related physiological and pathological processes. It signals through a tyrosine kinase-mediated pathway that is highly dependent on the positive feedback exerted by the platelet-derived secondary mediators, adenosine diphosphate (ADP) and thromboxane A (2) (TXA (2) ). Here, we aimed to analyze the tyrosine phosphoproteome of platelets activated with the CLEC-2 agonist rhodocytin to identify relevant phosphorylated tyrosine residues (p-Tyr) and proteins involved in platelet activation downstream of this receptor. We identified 363 differentially p-Tyr residues, corresponding to the majority of proteins previously known to participate in CLEC-2 signaling and also novel ones, including adaptors (e.g., DAPP1, Dok1/3, CASS4, Nck1/2), kinases/phosphatases (e.g., FAK1, FES, FGR, JAK2, SHIP2), and membrane proteins (e.g., G6F, JAM-A, PECAM-1, TLT-1). To elucidate the contribution of ADP and TXA (2) at different points of the CLEC-2 signaling cascade, we evaluated p-Tyr levels of residues identified in the analysis and known to be essential for the catalytic activity of kinases Syk(p-Tyr (525+526) ) and Src(p-Tyr (419) ), and for PLC gamma 2 activity (p-Tyr (759) ). We demonstrated that Syk phosphorylation at Tyr (525+526) also happens in the presence of ADP and TXA (2) inhibitors, which is not the case for Src-pTyr (419) and PLC gamma 2-pTyr (759) . Kinetics studies for the three phosphoproteins show some differences in the phosphorylation profile. Ca (2+) mobilization assays confirmed the relevance of ADP and TXA (2) for full CLEC-2-mediated platelet activation. The present study provides significant insights into the intracellular events that take place following CLEC-2 activation in platelets, contributing to elucidate in detail the CLEC-2 signalosome.
引用
收藏
页码:262 / 276
页数:15
相关论文
共 50 条
  • [1] A detailed proteomic analysis of rhodocytin-activated platelets reveals novel clues on the CLEC-2 signalosome: implications for CLEC-2 signaling regulation
    Parguina, Andres F.
    Alonso, Jana
    Rosa, Isaac
    Velez, Paula
    Gonzalez-Lopez, Maria J.
    Guitian, Esteban
    Ebble, Johannes A.
    Loza, Maria I.
    Garcia, Angel
    BLOOD, 2012, 120 (26) : E117 - E126
  • [2] The novel platelet activation receptor CLEC-2
    Suzuki-Inoue, Katsue
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2007, 127 : 17 - 18
  • [3] The novel platelet activation receptor CLEC-2
    Suzuki-Inoue, Katsue
    Inoue, Osamu
    Ozaki, Yukio
    PLATELETS, 2011, 22 (05) : 380 - 384
  • [4] Fucoidan Is a Novel Platelet Agonist for CLEC-2 Receptor
    Manne, Bhanukanth
    Getz, Todd M.
    Hughes, Craig
    Dangelmaier, Carol T.
    Watson, Steve P.
    Kunapuli, Satya P.
    BLOOD, 2012, 120 (21)
  • [5] Elucidating the CLEC-2 signaling cascade using a global proteomics approach
    Garcia, A.
    Parguina, A. F.
    Rosa, I
    Eble, J. A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 784 - 784
  • [6] Novel antiplatelet strategies targeting GPVI, CLEC-2 and tyrosine kinases
    Harbi, Maan H.
    Smith, Christopher W.
    Nicolson, Phillip L. R.
    Watson, Steve P.
    Thomas, Mark R.
    PLATELETS, 2021, 32 (01) : 29 - 42
  • [7] Novel platelet activation receptor CLEC-2: from discovery to prospects
    Suzuki-Inoue, K.
    Inoue, O.
    Ozaki, Y.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 500 - 501
  • [8] Novel interactions in platelet biology: CLEC-2/podoplanin and laminin/GPVI
    Ozaki, Y.
    Suzuki-Inoue, K.
    Inoue, O.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 191 - 194
  • [9] Novel platelet activation receptor CLEC-2: from discovery to prospects
    Suzuki-Inoue, K.
    Inoue, O.
    Ozaki, Y.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 44 - 55
  • [10] A detailed proteomic analysis of rhodocytin-activated platelets reveals novel clues on the CLEC-2 signalosome: implications for CLEC-2 signaling regulation (vol 120, pg e117, 2012)
    Parguina, A. F.
    Alonso, J.
    Rosa, I
    BLOOD, 2013, 121 (25) : 5104 - 5104